2042 related articles for article (PubMed ID: 818320)
1. Immunologic cross-reaction between human and mouse tyrosinases.
Ohtaki N; Miyazaki K
J Invest Dermatol; 1976 May; 66(5):327-9. PubMed ID: 818320
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical detection of tyrosinase in serum of patients with metastatic malignant melanomas. and from Hardy-Passey mouse melanomas.
DelVecchio VG; Burnett JB
Australas J Dermatol; 1976 Apr; 17(1):26-9. PubMed ID: 820325
[No Abstract] [Full Text] [Related]
3. Transfer of tyrosinase to melanosomes in Harding-Passey mouse melanoma.
Tomita Y; Hariu A; Kato C; Seiji M
Arch Biochem Biophys; 1983 Aug; 225(1):75-85. PubMed ID: 6412634
[TBL] [Abstract][Full Text] [Related]
4. Immunologic homogeneity and electrophoretic heterogeneity of mouse melanoma tyrosinases.
Otaki N; Miyazaki K
J Invest Dermatol; 1973 Dec; 61(6):339-43. PubMed ID: 4202157
[No Abstract] [Full Text] [Related]
5. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
Miranda M; Botti D
Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
[TBL] [Abstract][Full Text] [Related]
6. Inability of murine melanoma melanosomal "tyrosinase" (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems.
Edelstein LM; Cariglia N; Okun MR; Patel RP; Smucker D
J Invest Dermatol; 1975 May; 64(5):364-70. PubMed ID: 806638
[TBL] [Abstract][Full Text] [Related]
7. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
8. Aggregation equilibria of tyrosinase of Harding-Passey mouse melanoma.
Garcia-Borron JC; Solano F; Iborra JL; Lozano JA
Biochem J; 1985 May; 228(1):95-101. PubMed ID: 3924035
[TBL] [Abstract][Full Text] [Related]
9. The tyrosinase activity of melanosomes from the Harding-Passey melanoma: the absence of a peroxidase component in vitro.
Mufson RA
Arch Biochem Biophys; 1975 Apr; 167(2):738-43. PubMed ID: 804863
[No Abstract] [Full Text] [Related]
10. Multiple forms of tyrosinase from human melanoma.
Burnett JB; Seiler H
J Invest Dermatol; 1969 Feb; 52(2):199-203. PubMed ID: 4975466
[No Abstract] [Full Text] [Related]
11. Purification and properties of tyrosinase isoenzymes from hamster melanoma.
Pomerantz SH; Li JP
Yale J Biol Med; 1973 Dec; 46(5):541-52. PubMed ID: 4205121
[No Abstract] [Full Text] [Related]
12. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
Iwata K; Takeuchi T
J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinase isolated from mouse melanoma melanosome.
Miyazaki K; Seiji M
J Invest Dermatol; 1971 Aug; 57(2):81-6. PubMed ID: 4999637
[No Abstract] [Full Text] [Related]
14. Involvement of tyrosinase in melanin formation in murine melanoma.
Hearing VJ; Ekel TM
J Invest Dermatol; 1975 Feb; 64(2):80-5. PubMed ID: 804529
[TBL] [Abstract][Full Text] [Related]
15. Purification of hamster melanoma tyrosinases and structural studies of their asparagine-linked sugar chains.
Ohkura T; Yamashita K; Mishima Y; Kobata A
Arch Biochem Biophys; 1984 Nov; 235(1):63-77. PubMed ID: 6437339
[TBL] [Abstract][Full Text] [Related]
16. Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.
Dernałowicz-Malarczyk E; Kotłowska-Niećko I
Neoplasma; 1980; 27(4):345-53. PubMed ID: 6779209
[TBL] [Abstract][Full Text] [Related]
17. Antiserum against tyrosinase from mouse melanoma.
Ohtaki N; Miyazaki K
J Invest Dermatol; 1972 Apr; 58(4):238-41. PubMed ID: 4623203
[No Abstract] [Full Text] [Related]
18. Activation of tyrosinase in microsomes and melanosomes from B16 and Harding-Passey melanomas.
Menon IA; Haberman HF
Arch Biochem Biophys; 1970 Mar; 137(1):231-42. PubMed ID: 4985092
[No Abstract] [Full Text] [Related]
19. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
McEwan M; Parsons PG; Moss DJ
J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
